Salk Institute names two to board

Dr. Benjamin H. Lewis and Faye H. Russell have been elected to the board of the Salk Institute for Biological Studies.

The Salk Institute has also invited world-renowned cell biologist Dr. Jennifer Lippincott-Schwartz to join its faculty as a non-resident fellow.

Lewis is an associate clinical professor of Medicine at Columbia University and an attending physician at Columbia University Medical Center, the New York-Presbyterian Hospital in New York. Dr. Lewis has devoted his career to the prevention of cardiovascular disease. His particular focus is on the increased use of lifestyle approaches, medical therapies, and noninvasive, nonradioactive techniques-in particular, ultrasound-for the diagnosis and management of heart-disease patients.

Russell is a partner in Latham & Watkins’ North San Diego office where she assists emerging growth companies in developing and executing acquisition and licensing strategies. In addition, she advises companies on public and private equity and debt financings, including initial public offerings and venture financings. She is a member of the board of directors of Athena San Diego, an organization for executive women in the San Diego life sciences, technology, healthcare, and business communities, and has served on the board of directors of San Diego Venture Group.

Lippincott-Schwartz, is an investigator at the National Institute of Child Health and Human Development at NIH in Bethesda, Md., and studies the dynamic nature of cells and their organelles. She is a leading force in the development of superresolution imaging. Dr. Lippincott-Schwartz has been elected to the National Academy of Sciences and the National Institute of Medicine and is a fellow of the American Association for the Advancement of Science.